1. Medicines
  2. Rheumatology
  3. COSENTYX® (secukinumab)

Where can I get more information about Cosentyx?

Summary of product characteristics (SmPC) for Cosentyx Great Britain and Northern Ireland

These links will take you to the electronic medicines compendium (eMC) website, which is a non-Novartis website.

 

Patient information leaflet (PIL) for the 150mg injection pen for Cosentyx Great Britain and Northern Ireland

Patient information leaflet (PIL) for the 300mg injection pen for Cosentyx Great Britain and Northern Ireland

These links will take you to the electronic medicines compendium (eMC) website, which is a non-Novartis website.

The patient information leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Rate this content: 
No votes yet
UK | February 2022 | 187429
Rheumatology
Article
Print
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.